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Background: Pain is an important issue in end of life care. Although musculoskeletal pain is common in older
adults, it is rarely associated with the cause of death and may be overlooked as death approaches. Hence a major
target for improving quality of life may be being missed.
Methods: The aim of this study was to systematically search and critically review the literature on musculoskeletal
pain at the end of life. Amed, Cinahl, Internurse, Medline, Psych Info, Web of Knowledge and Cochrane review
databases were searched for relevant research up to September 2012. The search strategy combined key words
expanding the terms ‘palliative’ for population, ‘musculoskeletal’ for exposure, and ‘pain’ for outcome. Predefined
inclusion and exclusion criteria were applied.
Results: Five relevant papers and one letter to the editor were found, including case studies and epidemiological
research. Current evidence suggests musculoskeletal pain is common in older adults at the end of life and that it
can have a substantial impact on individual experience. No information about community based treatment of
musculoskeletal pain at the end of life was found.
Conclusion: Priorities for future research include high quality epidemiological studies to establish the prevalence,
natural history, impact, assessment, patient priorities and outcomes associated with musculoskeletal pain in the end
of life period, and intervention research that provides an evidence base for treatment.
Keywords: Palliative, Pain, Musculoskeletal, End of life, Systematic reviewBackground
Pain has been described as a more terrible lord of man-
kind than even death itself [1]; nevertheless it is known
that many people die with unnecessary pain [2]. Musculo-
skeletal pain is a common symptom that is frequently
under-reported and inadequately treated in older adults
[3], the stage of life when most people die [4]. Musculo-
skeletal pain has the potential to impact on end of life
care, especially as many of the first line strategies pro-
moted, including exercise and self-management [5] may
not be applicable or appropriate as death approaches [6].
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reproduction in any medium, provided the orcause of pain in older people [7] may be being overlooked
as it is rarely implicated as a cause of death, despite the
potential for musculoskeletal disease to be a substantial
cause of pain and discomfort in the dying person.
Musculoskeletal pain derives from a pathophysiologic-
ally diverse set of musculoskeletal conditions [8] includ-
ing osteoarthritis, rheumatoid arthritis and spinal
trouble. It is commonly classified according to pain loca-
tion (hip, knee, lower back) although most people with
chronic pain have pain at multiple sites [9]. One reason
the topic has remained largely unexamined is that most
studies of pain prevalence in the elderly are cross sec-
tional and provide no information about the progression
of pain with time [7,10]. Most studies of pain and other
symptoms at the end of life consider the needs of people
with a specific advancing progressive disease [11-13],
and do not include symptoms associated with co-morbidd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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musculoskeletal pain. This is compounded by the dearth
of research to inform the treatment of pain in the elderly
[5,14]. A recent review of pain management found no
well-designed studies of analgesia that specifically fo-
cused on elderly patients requiring palliative care [15].
Another reason for the lack of research in this area
may be that musculoskeletal pains are frequently consid-
ered to be part of the normal ‘wear and tear’ of aging
[5]. For instance, Klinkenberg et al [16] compared the
agreement between the reporting of symptoms and dis-
ease by elderly patients (n = 270) in research interviews,
with proxy reporting in after-death interviews with sig-
nificant others and after-death questionnaires completed
by General Practitioners (GPs). Osteoarthritis (OA) was
the chronic disease with the lowest concordance between
both patient and proxy report and between patient and
GP report, with patients reporting much higher prevalence
in both comparisons. Klinkenberg et al [16] suggested
that the reason for the poor concordance was that health-
care professionals and significant others were more likely
to recall the illness that led to death than a chronic disease
that was integrated into a patients daily life.
The prevalence of musculoskeletal pain is known to in-
crease with age until it stabilises around age 65 [17]. How-
ever, the prevalence of disabling pain that impacts on life
increases notably among older people into the oldest age-
groups [18]. The impact on individuals can be significant
[3]. A review of chronic pain prevalence in older people
found estimates ranging from 18-57% [19]. The wide
range was partly explained by the variation in definitions
used for chronic pain [19]. There is less precise informa-
tion about the prevalence, impact or treatment of muscu-
loskeletal pain at the end of life. Consequently it is
possible that a major cause of pain is being overlooked
and a potential target for improving quality of life is being
ignored. The objective of this study was to conduct a sys-
tematic search of the literature with the aim of highlight-
ing what is currently known about musculoskeletal pain in
older adults at the end of life and the identification of pri-
orities for future research.
Methods
Search strategy
A modified PICO search [18] was used to identify infor-
mation regarding musculoskeletal pain at the end of life.Table 1 Search process
PICO term Expanded search term
P ‘Palliative’ or ‘end of life’ or ‘terminal’ or ‘death and dying’
I ‘Arthralgia’ or ‘polyarthralgia’ or ‘pain’
O ‘Arthritis’ or ‘rheumatoid’ or ‘osteoarthritis’ or ‘musculoskeletal’
P + I + O Terms combined with ‘AND’No comparison group was included as a scoping search
had shown that there was limited literature available and
we therefore planned to keep the search parameters as
broad as possible. The key words used to define the
population were ‘palliative’, ‘end of life’, ‘death and dying’,
‘terminal care’ or ‘terminally ill’. ‘Musculoskeletal’, ‘arth-
ritis’, ‘osteoarthritis’ or ‘rheumatoid’ were used to define
the exposure whilst ‘pain’, ‘arthralgia’ or ‘polyarthralgia’
were used to define outcome. The databases searched
were Amed, Cinahl, Internurse, Medline, PsychInfo,and
Web of Knowledge (from inception to September 2012).
(See Table 1 for further details). As Internurse had a more
limited search function it was searched separately. The
Cochrane database was searched but no relevant review
was found. The grey literature was searched using www.
opengrey.eu. The reference lists of all relevant research pa-
pers found were searched for further citations. Independ-
ent advice about the search strategy was obtained from an
information specialist.
Study selection
Inclusion criteria were that papers must be written in
English and report original research that considered
adults aged 50 or older. There is no general agreement
about when old age begins [20]. This search used the
broad definition of 50+ as used by the World Health
Organisation [20], both to maximise the potential litera-
ture found and to acknowledge that socially constructed
concepts of age often include biological as well as
chronological factors. (However, no papers were found
which had to be excluded because they only focused on
younger adults). Papers that highlighted pain as a diag-
nostic feature of disease with the aim of delaying or
preventing death were excluded. Similarly studies about
the effect of pain on mortality and studies that docu-
mented the clinical course of musculoskeletal diseases
were excluded. Finally paediatric, microbiological, animal
and cadaveric research was also excluded.
Refworks web based bibliographical management soft-
ware was used to assist study selection. Identified studies
from all databases (except Internurse) were combined. Fol-
lowing the removal of duplicate papers 1633 remained.
Figure 1 summarizes the selection process. All papers were
initially sorted by title. The abstracts of papers were read
when the paper appeared relevant from the title or when it
was unclear from the title if the paper was relevant (73Medline Web of knowledge PsychInfo Cinahl Ahmed
813,136 4 443,679 20,030 29,261 478,730
416,896 1,171,198 26,285 133,016 677,575
123,750 7,413,381 64,124 33,391 199,139
1383 2192 85 41 236
Figure 1 Selection of Included Studies.
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ginal research about musculoskeletal pain at end of life, the
paper was read (12 papers). These twelve papers were read
by a second person to independently validate the inclusion
criteria. Four relevant papers and one ‘letter to the editor’
were included in this review. They comprised of three case
studies and two epidemiological studies. One paper, a case
study [21], located through Internurse was also included
making a total of six relevant studies in the review.
Quality assessment
Quality assessment of research is important to assess
trustworthiness [22]. However, eligibility criteria were de-
liberately kept broad to maximise the information avail-
able. Although case studies are generally considered to
provide a weak level of evidence they do provide valid and
useful information about complex clinical situations [22].
They also alert practitioners to rare side effects and bene-
fits of disease and treatments [23,24]. Hence they wereincluded in this review. Despite the importance of critical
appraisal no research was excluded on the basis of quality
assessment. Due to the diversity of impetuses behind the
papers a standard proforma was not used to extract data,
rather relevant facts were extracted though multiple read-
ings of the papers. Case study data is summarised in
Table 2 and epidemiological studies in Table 3.
Results
Case reports
Lewin et al’s [25] letter described the use of cervical
cordotomy for musculoskeletal pain in a 67 year old man
with metastatic oesophageal cancer and rheumatoid arthritis
(RA). Following chemotherapy he had persistent, severe
right hip and buttock pain at the site of an earlier total hip
replacement, which restricted mobility. As he responded
poorly to opioids and had a prognosis of less than a year the
cordotomy was performed enabling the patient to mobilise
independently till he died eleven months later.
Table 2 Study characteristics and key findings: case studies
Author Study aim Study population Key findings
Lewin (2012) To discuss percutaneous
cervical cordotomy for
non-cancer pain
Gentleman (67) with cancer
and RA.
Percutaneous cervical cordotomy gave effective
pain relief for last 11 months of life
Persistent, severe, right hip
pain limited quality of life (QoL)
Katz et al. (2008) To describe arthroplasty
for MSK pain at EoL
Older woman with metastatic
lung cancer & lymphoma. QoL
severely limited by hip OA
Surgery successful; complete relief of hip pain.
Increased mobility enabling independent living
for last year of life
Del Fabbro et al. (2007) To discuss temporary
palliative sedation
Woman (60’s) with lung cancer
and limited metastatic disease.
Chronic osteoporosis, OA and
chronic back pain
Uncontrolled severe pain despite opioid rotation
(oral morphine equivalent of 1440mgs in 24 hrs).
Temporary palliative sedation used with good effect
(Patient able to return home). Long term chronic
musculoskeletal pain (+ somatisation, depression
and terminal illness) contributed to complex
symptom control requirements at EoL.
Intractable lumber pain
Greenstreet (2001) To discuss concept of
total pain
Woman (early 50s) with colon
cancer, metastatic lung disease
& PE. History of OA and bilateral
knee arthroplasty. Significant pain
in left knee from chronic osteomyelitis
Pain exacerbated by movement
Treatment complex required. Including, high dose
morphine sulphate (460mgs SR 12hrly) + Corticosteroids
used as adjuvant to reduce inflammation of the knee.
+ IV antibiotics to promote comfort
Non pharmacological measures included a brace to
immobilise knee joint, crutches to reduce weight
baring and ensuring leg supported and elevated
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with lymphoma and a non-small cell lung cancer. Her
main symptom was pain due to advanced left hip OA.
This severely restricted her ability to mobilise. Her pain
had been treated with physiotherapy and ibuprofen with
minimal effect. She had a total hip replacement follow-
ing a full discussion of the enhanced risks of surgery.
Within a week she had complete relief from her left hipTable 3 Study characteristics and key findings: epidemiologic
Paper Smith et al. (2010)
Study Aim To describe the epidemiology of pain at the
Study Population Data obtained from The Health and Retireme
Study (USA)
Sampling Frame National probability sample of US household
Sample Population Community dwelling older adults who died w
24 months of final period of data collection (
Data Collection Telephone interviews (and some home visits)
Sample Characteristics Male = 52.3% Female 47.7%
Mean age, (SD): 75.7, (10.8)
Age distribution: 21% < 65; 24% > = 66–75:
36% > = 67–85:19% > 86
Terminal Diagnosis: Cancer 27.6%; Heart Dise
Frailty 11.8%; Sudden Death 16.7%; Other 14.
(62.2% had arthritis)
Key measure: Prevalence
Key Findings Arthritis strongly associated with pain at EoL
In final month of life pain prevalence was 60
with arthritis versus 26% in people without apain and regained full mobility following rehabilitation.
This enabled her to spend most of her final year of life
living independently.
Del Fabbro et al [27] discussed an unusually complex
case of a woman in her sixties with lung cancer with
limited metastatic disease and a history of osteoporosis,
OA, and chronic back pain. She was admitted to the pal-
liative care unit with intractable pain that was poorlyal studies
Borgsteede et al. (2007)
EoL To describe the prevalence of symptoms in patients
receiving palliative care at home
nt Study nested in the 2nd Dutch National Survey of
General Practice (DNSGP-2)
s A representative sample of 104 Dutch GPs
ithin
N = 4703)
Patients who died with an observation period of at
least 3 months in the survey year and were labelled
as palliative care patients by their GP (N = 429)
From GP records of GP/Patients encounters
Male 47%, Female 53%
Mean age (SD): 76.8 (13.9)
Age distribution: 28% < 70; 24% = 70–79:
31% = 80–89: 16% > 90
ase 29.7%:
2%
Terminal Diagnosis: Cancer 56%; Heart failure 11%;
COPD 3%; Other disease 25%; Multiple non cancer
diseases 5%
Key measure: Prevalence
(P < 0.001). The prevalence of musculoskeletal symptoms was
20% in patient physician encounters.
% in people
rthritis.
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equivalence of up to of 1600mgs daily). The main focus
of the paper is on the temporary palliative sedation that
was used to control delirium and enable assessment of
symptom severity whilst rotating opioids to maximise
analgesic affect with minimum side effects, enabling dis-
charge home for a period of weeks before death.
This case highlighted how the treatment of long term
chronic musculoskeletal pain may have inadvertently and
adversely affected the care needs as death approached. The
woman had been receiving muscle relaxants and opioid an-
algesia for chronic back pain since the death of her hus-
band. The possibility that she had somatised her grief and
depression during her bereavement is discussed. It is sug-
gested that this maladaptive coping mechanism of reques-
ting opioids for existential distress as well as physical pain,
contributed to the rapid escalation of opioids that led to
delirium and the necessity of temporary sedation [27].
Greenstreet [21] focused on ‘Hannah’: a woman in her
early 50s with colon cancer, metastatic lung disease and a
pulmonary embolism (PE). She had a history of OA and bi-
lateral knee arthroplasty. The main physical symptom was
pain in the left knee due to osteomyelitis. Hannah was not
fit for surgery and non-steroidal anti-inflammatory medica-
tion was inappropriate due to the risk of haemorrhage as
she was prescribed anticoagulant medication following her
PE. Corticosteroids and a course of intravenous antibiotics
were prescribed with the aim of reducing the inflammation,
and associated pain, caused by the osteomyelitis. Analgesia
was given in accordance with the WHO Cancer Pain Lad-
der [28] and a strong opioid (morphine) was gradually ti-
trated until a good analgesic effect was achieved at rest.
This was realised with 460 mg slow release morphine twice
daily. Breakthrough pain, commonly provoked through
movement remained. Non pharmacological measures to re-
duce these episodes of breakthrough pain included a brace
to immobilise the knee joint, crutches to minimise weight
bearing, and ensuring the leg was elevated when Hannah
was sitting. Psychological support, massage and aromather-
apy were also used to reduce pain perception.
Epidemiological papers
Smith et al [29] considered the epidemiology of pain dur-
ing the last two years of life. Information was obtained
from 4703 decedents (mean age 76), from The Health and
Retirement study, a longitudinal cohort study of commu-
nity dwelling adults living in the USA. Taking the last
interview before death participants were placed into one
of twenty four cohorts on the basis of the number of
months between interview and death and their responses
compared with the background prevalence of pain
amongst participants of the same age who did not die.
The authors found that the presence of arthritis was
strongly associated with pain at the end of life. Theprevalence of pain in the last month of life was 60% of
people with arthritis versus 26% among people without
arthritis (P <0.001). This did not differ by terminal disease
category, nor was there any evidence for an interaction be-
tween arthritis and any terminal disease category [29].
During the two years before death the prevalence of pain
remained stable at approximately 40% for people with
arthritis and 14% for people without arthritis, until the last
four months of life when it increased steadily to the preva-
lence figures reported above.
Borgsteede et al [30] reported on the prevalence of
symptoms in patients receiving palliative care at home.
Their study was completed within the framework of a na-
tionwide cross sectional study of general practice in the
Netherlands. A representative sample of participating GPs
received a questionnaire regarding patients who had re-
ceived palliative care and died at home. Information was
then retrieved from GP records, using the international
classification of primary care (ICPC), regarding the GP-
patient encounters in the last three months for 429 pa-
tients. Symptoms were classified into categories according
to ICPC chapters. Musculoskeletal symptoms had a 20%
prevalence in patient-physician encounters.
Discussion
The findings present a dichotomy of methods and focus
with two epidemiological papers that suggest that muscu-
loskeletal symptoms have a substantial impact at the end
of life in the general population and four cases studies
showing that musculoskeletal pain can be a significant
issue for individuals requiring unusually sophisticated pain
control measures including temporary sedation, cordo-
tomy, arthroplasty and very high dose opiates. No infor-
mation was found about the way that musculoskeletal
symptoms were assessed and treated in the general popu-
lation. Despite this, the findings do give some indication
of the prevalence, impact and treatment of musculoskel-
etal pain at the end of life.
Prevalence
The population based studies indicated that musculo-
skeletal pain is a common and significant issue at the
end of life. Smith et al’s [29] study, the first epidemio-
logical study to look at pain at the end of life, draws at-
tention to the fact that musculoskeletal disease may have
as much, if not more, effect on whether a person dies in
pain than the condition that is the cause of death. Un-
fortunately, Smith et al [29] do not define what is mean
by the term ‘arthritis’. This is important as prevalence
estimates of musculoskeletal disease occurrence can vary
considerably depending on the phenotype definition
[31]. Also 19% of Smith et al’s [29] data was obtained by
proxies who may have underreported musculoskeletal
symptoms [16].
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view and death to document a significant increase in
pain prevalence in people with arthritis as death
approached. The authors highlighted the limitations of
using cross sectional data in this fashion. Despite this,
the findings emphasise the need to be especially vigilant
for pain in people with co-morbid musculoskeletal dis-
ease in the final months of life [32]. Borgsteede et al [30]
supported this by showing that musculoskeletal symp-
toms were prevalent in at least 20% of patient-GP en-
counters during the last three months of life. This is
higher than the 14% annual prevalence of GP consulta-
tions for musculoskeletal disease in the general popula-
tion reported by Jordan et al [33]. However, the studies
were undertaken in different countries and used differ-
ent systems for classifying consultation data making dir-
ect comparison difficult. Furthermore, Borgsteede et al
[30] gave no information about the nature or severity of
the symptoms, nor does it discuss how, or whether, they
were successfully managed in practice. Borgsteed et al
[30] suggested that their study may have underestimated
the prevalence of musculoskeletal symptoms as GP’s
were unlikely to register all the symptoms affecting pa-
tients at the end of life and the records represented the
most important symptoms as perceived by the GPs, ra-
ther than documenting the patients perspective [30].
Smith et al [29] may also have a systematic bias under-
estimating the true prevalence of musculoskeletal pain.
The health and retirement study excluded people living
in institutions, and admission to care homes is com-
monly prompted by reduced physical functioning [34].
Although both population based studies found muscu-
loskeletal disease had a significant impact at the end of
life, the prevalence of symptoms recorded varied signifi-
cantly: 60% in Smith et al [29] and 20% in Borgsteede
et al [30]. As Smith et al [29] does not discuss how ‘arth-
ritis’ was defined and Borgsteede et al [30] do not dis-
cuss the nature of the musculoskeletal symptoms,
comparison is difficult. The extent of the disparity is
similar to that observed when estimates of musculoskel-
etal pain from population surveys are compared with es-
timates derived from coded primary care data, with
surveys consistently suggesting that only a minority of
people raise the issue of even severe musculoskeletal
pain with their GP [35]. Nevertheless the fact that these
figures do not more closely correspond provides tenta-
tive initial support for the idea that musculoskeletal pain
is common at the end of life, but underestimated as a
cause of pain by healthcare professionals. However, an
alternative explanation is that raising an issue in a GP
consultation is a proxy for severity causing patients to
request treatment. Even the lower figure of 20% preva-
lence suggests that large numbers of people may be sig-
nificantly affected by musculoskeletal pain. NeitherBorgsteede et al [30] or Smith et al [29] were specifically
investigating musculoskeletal pain at the end of life and
both papers reported that the levels of musculoskeletal
pain were new findings that had not been highlighted in
previous end of life care research. This emphasises the
need for more population based epidemiological studies
which specifically focus on musculoskeletal symptoms.
This is discussed further below.
Impact
The four case studies clearly demonstrated that muscu-
loskeletal pain can significantly impact on individuals in
diverse ways emphasizing the needs for individualised
assessment and treatment of musculoskeletal pain at the
end of life. However, as three of these studies describe
particularly complex situations it is not possible to ex-
trapolate any information about the impact of musculo-
skeletal pain to the general population. However the
importance of the case histories as illustration is that
they highlight that rational treatment targeted at comor-
bid musculoskeletal pain is a potentially important com-
ponent of all patients in pain nearing the end of life:
they powerfully challenge the assumption that pain in this
period should simply be attributed to the condition caus-
ing death without considering other concurrent explana-
tions. Neither of the population based studies discussed
the impact or treatment of musculoskeletal pain.
Treatment
Only one of the case studies, Katz et al [26], argued that
the treatment described; (total joint replacement), could
offer a potent and systematic treatment strategy in the
palliative care of patients with advancing progressive dis-
ease and concomitant musculoskeletal pain. There was a
dearth of studies about the treatments for musculoskel-
etal pain at the end of life in a primary care setting. This
is an important omission because, although most people
die in a hospital setting, the majority of the last year of
life is lived in the community, either at home or within a
care home [2,36].
A possible reason for the lack of information about
treatment is that either the standard tools advocated by
palliative care, or the treatments advocated for chronic
musculoskeletal pain, are effective. Palliative care pro-
motes the use of the World Health Organisation cancer
pain ladder [28] for systematic and effective pain man-
agement. Although there have been some studies that
consider the effectiveness of this tool for cancer pain
[37,38], there appears to be no study that considers
whether this is an effective way to manage musculoskel-
etal pain at the end of life. There are, indeed, significant
limitations in the evidence base for the use of opioids in
chronic musculoskeletal pain [39-41] and the side effects
of opiates meant they were ineffective in two of the case
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ing the use of opiates for short term incident or episodic
pains [42], like the breakthrough pain provoked by
movement described by Greenstreet [21].
The fact that Smith et al [29] reported that the preva-
lence of pain was similar across the different categories
of terminal illness but substantially greater for people
with concomitant arthritis, alongside the substantial
body of evidence that many older adults live with
chronic pain associated with musculoskeletal disease
[3,7] tentatively suggests that musculoskeletal pain is not
being effectively treated at the end of life. Rather, it is
being overlooked as a potentially common cause of pain
whilst attention is focused on supporting symptoms as-
sociated with concurrent advancing progressive disease.
Priorities for future research
The limited literature identified emphasises the need for
more research into almost every aspect of this topic.
However, it is suggested that the three key priorities for
future research are:
1) Research that denotes the prevalence, natural history,
causes, outcomes, and other factors associated with
musculoskeletal pain at the end of life.
More epidemiological research that is specifically
designed to focus on the factors that influence the
prevalence of musculoskeletal pain at the end of life
is needed. Studies should use core standard
definitions of musculoskeletal pain to allow
comparisons between different studies and enable
meta-analysis of results [43]. In particular a
longitudinal cohort study of people with
musculoskeletal disease would help identify key
factors that influence the prevalence of
musculoskeletal pain as death approaches.
Epidemiological research would also help
differentiate the effect of psychosocial factors and
treatment factors that influence the experience of
pain at the end of life.2) Research that describes the impact of musculoskeletal
pain on older adults at the end of life.
Qualitative research, with different groups of older
adults, including the frail elderly, would help
elucidate how musculoskeletal pain affects the
options and choices available at the end of life. This
is particularly important as many of the symptoms
associated with musculoskeletal disease are also
commonly associated with other advancing
progressive incurable disease [11-13]. As
musculoskeletal disease can be overlooked at this
time [16] more information would help elucidate
whether musculoskeletal pain is a significant factor
in the end of life experience of the elderly.3) Research that provides an evidence base for treatment
of musculoskeletal pain at the end of life.
Research is needed to document how
musculoskeletal pain is being treated at the end of
life and which treatments are most effective. Studies
that consider the treatment given in a primary care
setting are a particularly priority since much of the
last year of life is lived in the community, either at
home or within a care home [2,35]. Pharmacological
and non-pharmacological treatments that are
known to be efficacious in the short term like intra-
articular injections and topical NSAIDs [44] may be
worth re-examining as short acting analgesic
measures are frequently valuable at the end of life.
Case series that rigorously and systematically describe
the effect of treatment on a consecutive series of
patients with musculoskeletal pain at the end of life
should be instigated. For instance, a case series
looking at arthroscopy, as described by Katz et al [26],
would demonstrate whether the procedure was
clinically acceptable and feasible for a range of
patients. Finally, there is a need for randomised
controlled trials to ensure that the treatments are
effective and safe within a general population.Conclusion
This systematic search of the literature suggests that mus-
culoskeletal disease is an important issue that can signifi-
cantly impact on pain in the elderly at the end of life. It
highlights the high prevalence of musculoskeletal symp-
toms at the end of life and the need for frequent assess-
ment of musculoskeletal pain as death approaches.
However, it also draws attention to the dearth of literature
regarding evidence based treatment for people dying with
musculoskeletal pain. One reason for the previous oversight
of this important topic may be that chronic disease that is
assimilated into a patient’s daily life is less likely to be the
focus of concern than a concomitant advancing progressive
disease [16]. Priorities for research include epidemiology
studies of musculoskeletal pain at the end of life and its im-
pact on individuals, together with qualitative research into
patient priorities related to this topic and research designed
to provide an evidence base for treatment at this time.
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